Dana Allwein

As many as 1 in 3 infected with COVID-19 have longer-term neurological or mental health symptoms.

Recently, the U.S. Food and Drug Administration approved a new device for challenging aneurysms — the Woven EndoBridge®, or WEB.

Deep brain stimulation has been used to successfully treat patients with movement disorders and psychiatric disorders, and obesity has emerged as another possible clinical application.